The immune system makes use of major histocompatibility complex class I (MHC I) molecules to present peptides to other immune cells, which can evoke an immune response. Within this process of antigen presentation, the MHC I peptide loading complex, consisting of a transporter associated with antigen processing TAP, MHC I, and chaperones, is key to the initiation of immune response by shuttling peptides from the cytosol into the ER lumen. However, it is still enigmatic how the flux of antigens is precisely coordinated in time and space, limiting our understanding of antigen presentation pathways.
Introduction
To avoid threats from pathogens and malignantly transformed cells, the immune system elaborated sophisticated ways to process antigens for their presentation to different immune cell subsets via MHC I molecules.
1,2 The transporter associated with antigen processing (TAP) is a central assembly unit of the peptide-loading complex (PLC). TAP translocates cytosolic antigenic peptides into the endoplasmic reticulum (ER) for subsequent loading onto MHC I molecules.
3,4 Peptide-MHC complexes are then released from the PLC and traffic to the cell surface. An important step in the understanding of MHC I antigen presentation pathways was recently achieved by the structure determination of the human PLC. 5 As bait, the TAP inhibitor ICP47 was employed to arrest and isolate endogenous PLCs.
Antigen processing comprises a number of crucial steps that shape the immune response. Within the PLC, TAP is a major target for tumor and viral immune evasion. 6, 7 The viral inhibitor ICP47 encoded by herpes simplex virus represents one of the most potent immune suppressors. [8] [9] [10] Its active domain is located in the N-terminal region (residue 2-34), which inhibits MHC I antigen presentation by blocking TAP and thus the supply of antigenic peptides. 11, 12 Upon binding to TAP, the active domain of ICP47 adopts two a-helices connected by a exible loop. [13] [14] [15] The consecutive region (residues 35-55) is required for stabilization of TAP by a conformational arrest.
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Although many steps in antigen processing have been elucidated, 1 it is less clear how the events are linked and how the ux of peptides is spatiotemporally coordinated. Hence, conditional tools are required to control distinctive check-points in the antigen processing pathway with high accuracy in time and space.
Optogenetics and optochemical biology have emerged to modulate biological processes. Light enables a spatiotemporal regulation of bioactivity. So far, the repertoire of photoresponsive biomolecules ranges from caged ATP, second messengers, and neurotransmitters to peptides and proteins. [17] [18] [19] Protein caging is typically achieved by masking amino acids, which are essential for activity or ligand interaction. Genetic code expansion promoted the incorporation of caged unnatural amino acids by amber stop codon, but is restricted to side-chain functionalities. [20] [21] [22] In contrast, chemical protein synthesis allows for the exible integration of photo-sensitive moieties and generation of caged proteins equipped with light-sensitive units.
With the PLC being one of the key checkpoints in MHC I antigen presentation, we targeted TAP as its central translocation unit to control its functional activity by light. We designed a photo-sensitive ICP47 to selectively arrest TAP in situ, which results in the conditional blockage of the substratebinding pocket and thus inhibits peptide transport from the cytosol into the ER lumen. Photo-conditional ICP47 (pc-ICP47) variants were designed to specically block antigen supply by TAP inhibition and instantaneously initiate TAP activity upon pc-ICP47 photo-cleavage (Fig. 1) . Inhibition of peptide translocation and its activation by light was analyzed by a series of peptide binding and translocation assays. In-cell applications demonstrate that pc-ICP47 blocks TAP-dependent peptide translocation, which is reversed aer illumination. We report on the development of pc-ICP47, which can be used as a molecular plug for the PLC in order to enable control of peptide translocation in time and space by light.
Results and discussion
Design and photo-scission of photo-conditional TAP inhibitors
To establish a synthetic route providing access to backbonemodied ICP47, we employed 9-uorenyl-methoxycarbonyl (Fmoc) solid-phase peptide synthesis. Since the site-specic incorporation of photo-labile amino acids in backbonemodied proteins cannot be achieved by genetic or enzymatic approaches, the synthetic strategy was adjusted to engineer pc-ICP47 variants in good yield. We rationalized that positions in the exible loop of the active region of ICP47 are likely to tolerate substitutions in contrast to the two a-helices.
11, 12 We therefore replaced residue Asn14 or Met15 by the photo-sensitive 3-amino-3-(2-nitrophenyl)propionic acid (Anp) in either S or R stereo conguration (Fig. 2a) . It is worth mentioning that the additional rotatable bond of the photo-labile b ). Aer purication, the identity of all variants was conrmed by high-resolution mass spectrometry (Fig. S1-S4 and Table S1 †). The photo-conditional ICP47 variants displayed an a-helical conformation similar to unmodied ICP47 ( Fig. S5 and Table S2 †).
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We next examined the photo-cleavage kinetics of the pc-ICP47 variants. Illumination at 365 nm (185 mW cm À2 ) for various intervals led to clean fragmentation of all photo-labile variants (Fig. 2b , S6 and S7 †). All pc-ICP47 variants displayed a similar photo-scission rate of t 1/2 z 12 s, and the photolytic fragmentation was virtually completed within 60 s, leading to more than 90% fragmentation ( Fig. 2b and Table S3 †) . The position and stereo-conguration of the photo-cleavable amino acid had no signicant inuence on the photolytic kinetics. The fast photo-activation along with a clean fragmentation is essential for a precise control of cellular processes. 
Peptide binding to TAP by light
We rst examined the inhibitory activity of all pc-ICP47 variants prior to photo-cleavage (Fig. 3) . A dened concentration of the uorescein (FL) labeled reporter peptide (RRYC (Fig. 3a and Table S4 †). We next exploited peptide binding aer photoillumination. It is important to mention that short fragments of ICP47 generated upon photo-cleavage display no detectable affinity for TAP. 12 (Fig. 3b) . In contrast, the activity of TAP alone or in complex with unmodied ICP47 2-34 was not affected by illumination.
Peptide translocation triggered by light
We next analyzed whether the antigen translocation complex could be reactivated upon illumination. TAP-dependent transport of a uorescent peptide (RRYQNSTC FL L, named NST-F) was monitored using microsomes isolated from human Burkitt's lymphoma (Raji) cells (Fig. 4) . Aer translocation, the NST-F peptide is specically N-core glycosylated in the ER lumen based on the glycosylation targeting sequence (NST). 24, 25 Before illumination, TAP-dependent peptide translocation was blocked by pc-ICP47 2-34 to a level similar to unmodied ICP47 2-34 (>85% inhibition; Fig. 4a ). The inhibition was dependent on the position of the photo-cleavable amino acid as demonstrated by a higher IC 50 value of ICP47 2-34 modied with the photo-cleavable amino acid at position 14 compared to position 15. Consistent with the peptide binding data, the blockage was not affected by the stereochemistry of the photo-labile amino acid, due to the conformational freedom of the b 3 -amino acid Anp (Fig. S8 †) . Upon photo-stimulation, peptide translocation of pc-ICP47 blocked TAP was restored (>90%). A slightly lower efficiency was achieved for pc-ICP47 modied at position 14 ($85%). Photoactivation of TAP resulted in a fast restoration of peptide transport into the ER lumen (Fig. 4b) . Importantly, the light induced recovery of peptide translocation occurred at a rate comparable to the one obtained for photo-cleavage of free pc-ICP47 2-34 , demonstrating that the photolysis kinetics of pc-ICP47 2-34 in the unbound and bound state are similar.
Based on the optimal position and stereochemistry of the photo-labile amino acid, we also synthesized a full--interacting photo-conditional inhibitor, which is required to stabilize the TAP complex and to isolate the native PLC.
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For pc-ICP47 15R-Anp 2-55 , similar inhibition constants, photofragmentation kinetics, and photo-activation of TAP were obtained (Fig. 4a , S9-S11 and Table S4 †). Once arrested either by photo-conditional or unmodied viral inhibitors, the TAP complex is stabilized. However, aer photo-exposure, the pc-ICP47 2-55 arrested TAP complex disassembles, whereas the complex containing the unmodied ICP47 2-55 remains stable (Fig. S12 †) .
Light-controlled antigen translocation at single-cell resolution
Finally, we examined pc-ICP47 2-34 on TAP activity in B cells (Raji), a frequently employed lymphoma cell line as a model for antigen presentation. The TAP-dependent translocation of uorescent peptides in the ER was monitored by ow cytometry (Fig. 5a ). The plasma membrane was semi-permeabilized by streptolysin O (SLO) while ER membranes stayed intact, which has been previously evaluated in cells expressing cytosolic GFP and ER-resident mCherry. 25 Dened concentrations of SLO led to a loss of cytosolic GFP but retained an intact mCherry signal, demonstrating that only the plasma membrane but not the ER membrane is semi-permeabilized. Cells pre-incubated either with unmodied ICP47 2-34 or pc-ICP47 2-34 showed no peptide transport activity above the background signal of ATP depleted cells.
Aer illumination, peptide translocation was recovered for TAP blocked by pc-ICP47 2-34 , whereas unmodied ICP47 keeps TAP in its arrested state (Fig. 5b and c) . Aer photocleavage of pc-ICP47 2-34 , peptide translocation was restored to the level of active TAP. Statistical analysis of independent experiments further corroborated the results, accentuating that TAP and peptide translocation into the ER can be controlled by light using pc-ICP47 2-34 (>90%; Fig. 5c ). Importantly, the cell viability is not affected by the photo-activation (Fig. S13 †) .
To generalize the versatile use of photo-conditional inhibitors, we assigned the single-cell based antigen translocation assay to primary cells of human donors. Hence, we isolated human blood-derived monocytes that show high TAP activity among other immune cell subsets. 25 In the presence of pc-ICP47 2-34 , peptide translocation was blocked to a similar extent as with the unmodied TAP inhibitor. Upon illumination, TAP and thus peptide translocation was restored in monocytes preincubated with pc-ICP47 2-34 , but not in cells with unmodied ICP47 (Fig. 5d and S14 †) . Thus, we have demonstrated that pc-ICP47 2-34 blocked TAP in different cell types and antigen translocation can be unleashed by light.
Conclusions
We developed a methodology to control antigen processing via a photo-conditional checkpoint blockade of the antigen translocation complex TAP. We report on the design and characterization of the photo-conditional TAP inhibitor ICP47 to activate the PLC and subsequent TAP-dependent peptide translocation. The engineered ICP47 possessed a high light-sensitivity and fast photo-cleavage, which proved to be crucial for in situ activation of the PLC. Peptide translocation, mediated by TAP within the PLC, was markedly inhibited by synthetic pc-ICP47 and exclusively re-activated upon illumination in human cell lines and primary immune cells.
As the synthetic TAP inhibitor ICP47 provides new angles to study immune surveillance mechanisms, we foresee that the orthogonal modality will be a valuable approach to probe and manipulate the PLC. For instance, the role of the PLC in different antigen presentation pathways is not yet fully understood, and more comprehensive studies will require precise spatiotemporal control of its cellular activity. The photoconditional viral inhibitors will help to elucidate the inuence of the PLC function in primary immune cells and to probe antigen processing pathways in situ. The photo-cleavable inhibitors may open new avenues for time-resolved cryo-EM and super-resolution microscopic analyses to reveal the transient states of the assembly and disassembly of the PLC. To date, no light-controllable synthetic inhibitors are available to inuence TAP-dependent antigen processing with high temporal resolution. The development of an intervention toolbox to modulate checkpoint in antigen processing continues to be an important aspect of our research.
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